Stay updated on SAGE-217 Efficacy in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 Efficacy in Major Depressive Disorder Clinical Trial page.

Latest updates to the SAGE-217 Efficacy in Major Depressive Disorder Clinical Trial page
- Check6 days agoChange DetectedThe NIH announcement banner about the transition from “Artificial Intelligence” to “Super Intelligence” is no longer displayed; the study page still shows a 403 error.SummaryDifference1%

- Check13 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces an NIH-wide transition and says some content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now shows a 403 Forbidden error instead of study details, indicating an access or server issue that hides the previous content from view. The visible page elements are limited to site chrome and footer, with no study data presented.SummaryDifference19%

Stay in the know with updates to SAGE-217 Efficacy in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 Efficacy in Major Depressive Disorder Clinical Trial page.